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Development of dental clinical  
research in Brazil – a few (new) ethical 
challenges
We have witnessed a growth in dental clinical research in Brazil over the last three decades, both qualitatively and quantitatively. This 
claim is supported by the annual meetings of the Brazilian Society of 
Dental Research. In its 2011 edition, the event has showcased more than 
2,000 approved studies – many of which represent clinical research. The 
growing participation of Brazilian researchers in meetings of the Inter-
national Association for Dental Research (IADR) also reflects this trend, 
further confirming the international excellence of the dental research 
conducted in our country.
As to the ethical issue, many advances have been made. The dental 
community has adhered to and complied with the parameters of the ethi-
cal regulations put forth by CNS Resolution N. 196/96. A noteworthy 
effort has been made by dental researchers to obtain free and informed 
consent by research subjects, and greater care has been taken in evaluat-
ing the risks and benefits of research projects.
Nevertheless, as is inherent to the dynamics of scientific research, new 
challenges continue to present themselves. Historically, dental research 
in Brazil has been conducted in teaching and research institutions, often 
in the form of activities connected with graduate programs supported 
by funds from these institutions or from funding agencies, all from the 
public sector.
This scenario has been changing, and a growing participation by pri-
vate teaching institutions has been observed, albeit still with a strong 
contribution from public research funding agencies.
I see a strong trend towards private companies taking a greater stake 
as collaborators of dental research, along the lines and in the scale of 
the collaborations already observed in other healthcare areas, such as 
medical research in the field of pharmaceuticals. Today, what we see is 
no longer a marginal participation, whereby a firm donates a product 
to conduct experiments, but rather an expanded model, through multi-
center and international research, where the sponsor/company claims an 
effective participation in the planning of the study and contributes with 
significant financial support.
This model is now a global trend. In principle, I believe that private 
enterprise-sponsored scientific research is a positive endeavor, in that it 
may bring to life large-scale research projects for which public agencies 
have neither the interest nor the resources required to fund them.
This new reality, however, entails some new ethical challenges.
Questions arise as to the interests in the commercial gains by private 
firms acting as research sponsors, as a result of the development and/or the 
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scientific certification of commercial products. These 
interests – which are fair per se – should be consid-
ered as normal; the ethical question here is that they 
cannot be the determinant factor of the research. 
Thus, these interests should be harmonized with the 
interest of science and those of the researcher, e.g., 
to abide by the ethical commitment to divulge the 
research results regardless of the consequences to the 
image of the product being researched.
The so called “open research”, where the sponsor 
can determine how the results will be used, may be 
justified by strategic interests concerned with pro-
tecting societies and the common good, but this ap-
proach becomes unethical when these interests are 
predominantly unilateral or restricted to a minority.
The interests of sponsors should also be harmo-
nized with those of society in connection with the 
use of public equipment, particularly when the re-
search entails using research facilities or personnel 
trained and/or funded by public institutions. This 
same consideration should be borne in mind when 
the research involves both public health care institu-
tions and those assisted by them, causing the study 
to ultimately make use of already limited public 
healthcare resources.
Additionally, one must consider the issues relat-
ing to the transfer of technology. Brazil and the Bra-
zilians should not be viewed as a granary or a herd 
for the development of research. Brazilian research-
ers should not be satisfied with just the occasional 
credit received when the research is published. We 
should endeavor to establish effective partnerships 
made through formal contracts, so that the benefits 
achieved by the experiment may be shared with the 
Brazilian society.
Most Brazilian researchers conduct their studies 
according to ethical standards, but they need – and 
deserve – to receive support so that they may con-
tinue to do so.
In this sense, two major fronts should be con-
sidered. One refers to a set of actions aiming at 
strengthening the ethical appreciation system, which 
in Brazil goes by the name of CEPs/CONEP, which 
is responsible not only for looking after the interests 
of research subjects, but also for conceptualizing its 
own existence and acting as a major partner to re-
searchers, standing by their side so that they don’t 
feel unattended in face of the overpowering interests 
of institutions.
Another important front is to guarantee the 
transparency of the whole research development 
process. To this end, national and public access re-
search registries are being established in our coun-
try, such as the Plataforma Brasil and the REBEC 
– Registro Brasileiro de Ensaios Clínicos, which act 
together and also with similar international regis-
tries (International Clinical Trials Registries Plat-
form – ICTRP). The greater the research conduct-
ed behind closed doors, the harder it is to preserve 
the legitimate interests of science and the common 
good; conversely, the greater the transparency, the 
more unreservedly good, ethical and competent re-
searchers can count on the understanding and sup-
port of civil society for their honorable work.
